Clinical Trial Update: Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 trial update for Propiverine Hydrochloride Extended-Release Capsule in Overactive Bladder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Propiverine Hydrochloride Extended-Release Capsule (propiverine hydrochloride)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED